Viewing Study NCT01662258



Ignite Creation Date: 2024-05-06 @ 12:48 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01662258
Status: WITHDRAWN
Last Update Posted: 2016-04-19
First Post: 2012-08-03

Brief Title: Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Sponsor: University of Pittsburgh
Organization: University of Pittsburgh

Study Overview

Official Title: Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: WITHDRAWN
Status Verified Date: 2016-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Decision by NIH
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NIHCAP
Brief Summary: This is a prospective interventional study to assess laboratory testing which will identify the microbial cause of pneumonia This in turn will allow targeted antimicrobial agent selection for patients with community acquired-pneumonia CAP

Hypothesis 1 To determine if Targeted strategy is non-inferior to Empiric therapy with respect to outcome endpoints 2 To assess the use of innovative POC tests allows targeted narrow-spectrum antimicrobial therapy 3 To determine if Targeted strategy is superior to Empiric therapy in patients with viral pneumonia
Detailed Description: The study will be conducted at five academic medical university sites with 7 hospitals Empiric therapy is defined as selection of antibiotic therapy based on the 2007 ATS-IDSA guidelines in which broad-spectrum antibiotics are recommended and microbial cause is uncertain

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None